Ebselen Clinical Trials
2 recruitingDrug
Phase 21Phase 31
Showing 1–2 of 2 trials
Recruiting
Phase 3
SPI-1005 for the Treatment of Meniere's Disease (Open Label)
Meniere's DiseaseMénière's Disease
Sound Pharmaceuticals, Incorporated200 enrolled8 locationsNCT06859788
Recruiting
Phase 2
SPI-1005 in Adults Receiving Cochlear Implant
Hearing LossCochlear Trauma
Sound Pharmaceuticals, Incorporated40 enrolled1 locationNCT06340633